Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cuetter

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Neurology|January 1, 1997
Cervical radiculopathiesA Cuetter
The American Journal of Emergency Medicine|July 1, 1996
Association of intravenous phenytoin toxicity with demographic, clinical, and dosing parametersL Binder, J Trujillo, D Parker, et al.
Archives of Neurology|August 1, 1986
Peripheral dystoniaB Scherokman, F Husain, A Cuetter, et al.
Lancet (London, England)|December 20, 1986
Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosisL Jacobs, A M Salazar, R Herndon, et al.
Archives of Neurology|June 1, 1987
Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind studyL Jacobs, A M Salazar, R Herndon, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Neurology|January 1, 1997
Cervical radiculopathiesA Cuetter
The American Journal of Emergency Medicine|July 1, 1996
Association of intravenous phenytoin toxicity with demographic, clinical, and dosing parametersL Binder, J Trujillo, D Parker, et al.
Archives of Neurology|August 1, 1986
Peripheral dystoniaB Scherokman, F Husain, A Cuetter, et al.
Lancet (London, England)|December 20, 1986
Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosisL Jacobs, A M Salazar, R Herndon, et al.
Archives of Neurology|June 1, 1987
Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind studyL Jacobs, A M Salazar, R Herndon, et al.
Pageof 1